Golden Sara E, Disher Natalie, Dieckmann Nathan F, Eden Karen B, Matlock Daniel, Vranas Kelly C, Slatore Christopher G, Sullivan Donald R
Center to Improve Veteran Involvement in Care, VA Portland Health Care System (VAPORHCS), Portland, OR, USA.
School of Nursing, Oregon Health and Science University (OHSU), Portland, OR, USA.
PEC Innov. 2022 Oct 21;1:100094. doi: 10.1016/j.pecinn.2022.100094. eCollection 2022 Dec.
Evidence-based decision support resources do not exist for persons with lung cancer. We sought to develop and refine a treatment decision support, or conversation tool, to improve shared decision-making (SDM).
We conducted a multi-site study among patients with stage I-IV non-small cell lung cancer (NSCLC) who completed or had ongoing lung cancer treatment using semi-structured, cognitive qualitative interviews to assess participant understanding of content. We used an integrated approach of deductive and inductive thematic analysis.
Twenty-seven patients with NSCLC participated. Participants with prior cancer experiences or those with family members with prior cancer experiences reported better preparedness for cancer treatment decision-making. All participants agreed the conversation tool would be helpful to clarify their thinking about values, comparisons, and goals of treatment, and to help patients communicate more effectively with their clinicians.
Participants reported that the tool may empower them with confidence and agency to actively participate in cancer treatment SDM. The conversation tool was acceptable, comprehensible, and usable. Next steps will test effectiveness on patient-centered and decisional outcomes.
A personalized conversation tool using consequence tables and core SDM components is novel in that it can encourage a tailored, conversational dynamic and includes patient-centered values along with traditional decisional outcomes.
目前不存在针对肺癌患者的循证决策支持资源。我们试图开发并完善一种治疗决策支持工具或对话工具,以改善共同决策(SDM)。
我们在完成或正在接受肺癌治疗的I-IV期非小细胞肺癌(NSCLC)患者中开展了一项多中心研究,采用半结构化认知定性访谈来评估参与者对内容的理解。我们运用了演绎和归纳主题分析的综合方法。
27名NSCLC患者参与了研究。有过癌症经历的参与者或有家庭成员有过癌症经历的参与者表示,他们对癌症治疗决策的准备更充分。所有参与者都认为该对话工具将有助于理清他们对治疗价值观、比较和目标的思考,并帮助患者与临床医生更有效地沟通。
参与者表示,该工具可能会赋予他们信心和能力,使其积极参与癌症治疗的共同决策。该对话工具是可接受的、可理解的且可用的。下一步将测试其对以患者为中心的决策结果的有效性。
使用后果表和核心共同决策组件的个性化对话工具具有创新性,因为它可以促进一种量身定制的对话动态,并纳入以患者为中心的价值观以及传统的决策结果。